Nexus of ocular motility and dry eye.
Binocular vision anomalies
dry eye disease
refractory dry eye
vision therapy
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
medline:
10
4
2023
entrez:
7
4
2023
pubmed:
8
4
2023
Statut:
ppublish
Résumé
To evaluate the effectiveness of vision therapy (VT) in patients with chronic presumed refractory dry eye disease (DED) and concurrent nonstrabismic binocular vision anomalies (NSBVAs). To propose an algorithmic approach to manage patients with refractory DED. Thirty-two patients with chronic (>1 year) presumed refractory DED and NSBVA were prospectively evaluated. The baseline dry eye evaluation and comprehensive orthoptic evaluation were done. VT was administered by a trained orthoptist for 2 weeks. The binocular vision (BV) parameters and percentage subjective improvement were assessed after the VT. On evaluation, 12 patients (37.5%) had both DED and NSBVA, and 20 patients (62.5%) had only NSBVA. Twenty-nine patients (90.62%) showed significant improvement in BV parameters following VT. Binocular near point of accommodation (median, range) improved from 17 (8-40) to 12 (5-26) mm (P value < 0.0001), and near point of convergence (median, range) improved from 6 (3-33) to 6 (5-14) (P value 0.004) with VT. Thirty-one patients (96.87%) reported symptomatic improvement after VT, and 62.5% of these showed more than 50% improvement in symptoms. The present study confirms the beneficial role of VT in the treatment of patients with DED with concurrent NSBVA. It is essential to diagnose and treat NSBVA in patients with DED to ensure complete relief of symptoms and patient satisfaction. As there is a significant overlap between symptoms of dry eye disease and that of NSBVA, a complete orthoptic evaluation is recommended in all patients presenting with refractory dry eye disease related symptoms.
Identifiants
pubmed: 37026299
pii: IndianJOphthalmol_2023_71_4_1546_373526
doi: 10.4103/IJO.IJO_3364_22
pmc: PMC10276717
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1546-1550Déclaration de conflit d'intérêts
None
Références
Optom Vis Sci. 2015 Sep;92(9):e214-21
pubmed: 26164313
Optom Vis Sci. 2021 Oct 1;98(10):1160-1168
pubmed: 34678836
Indian J Ophthalmol. 2020 Dec;68(12):2835-2846
pubmed: 33229659
Cornea. 2004 Nov;23(8):762-70
pubmed: 15502475
J Clin Med. 2022 Apr 25;11(9):
pubmed: 35566533
Ophthalmology. 2007 Jan;114(1):76-9
pubmed: 17070588
Clin Ophthalmol. 2015 Sep 16;9:1719-30
pubmed: 26396495
J Vocat Behav. 2020 Jun;119:103435
pubmed: 32382161
J Pediatr Ophthalmol Strabismus. 2021 Jul-Aug;58(4):224-231
pubmed: 34288760
Ocul Surf. 2009 Oct;7(4):199-211
pubmed: 19948103
Curr Eye Res. 2020 Apr;45(4):428-434
pubmed: 31573824
Sci Rep. 2016 Oct 04;6:33083
pubmed: 27698364
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4753-61
pubmed: 14578396
Eye Contact Lens. 2018 May;44(3):e10-e12
pubmed: 27203793
Clin Ophthalmol. 2021 Feb 22;15:759-767
pubmed: 33654374
Optometry. 2009 Dec;80(12):702-16
pubmed: 19932444
J Optom. 2014 Oct-Dec;7(4):178-92
pubmed: 25323640
Case Rep Ophthalmol. 2013 Sep 07;4(3):105-8
pubmed: 24163676
Front Integr Neurosci. 2012 Oct 17;6:94
pubmed: 23087627
Clin Ophthalmol. 2017 May 05;11:861-869
pubmed: 28503063
Cureus. 2021 Aug 24;13(8):e17411
pubmed: 34589322
Arch Ophthalmol. 2000 May;118(5):615-21
pubmed: 10815152
Am J Ophthalmol. 2014 Apr;157(4):799-806
pubmed: 24388838
Cornea. 2016 Mar;35(3):318-22
pubmed: 26785301
Int Ophthalmol. 2020 May;40(5):1135-1141
pubmed: 31916061
Am J Ophthalmol. 2006 Aug;142(2):264-70
pubmed: 16876507